Monocyte-platelets aggregates as cellular biomarker of endothelium- dependent coronary vasomotor dysfunction in patients with coronary artery disease

Journal of Cardiovascular Translational Research

Volumn 7, Issue 1, 2014, Pages 1-8

  Di Serafino, Luigi ^a   Sarma, Jaydeep ^a   Dierickx, Karen ^a   Ntarladimas, Ioannis ^a   Pyxaras, Stylianos A ^a   Delrue, Leen ^a   De Bruyne, Bernard ^a   Wijns, William ^a   Barbato, Emanuele ^a   Bartunek, Jozef ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Endothelial dysfunction; Fractional flow reserve; Monocytes; Platelets

Indexed keywords

ADULT; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; ENDOTHELIAL DYSFUNCTION; FEMALE; FRACTIONAL FLOW RESERVE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOCYTE PLATELET AGGREGATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STABLE ANGINA PECTORIS; VASOMOTOR DISORDER; VASOMOTOR REFLEX;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CARDIAC PACING, ARTIFICIAL; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PLATELET ADHESIVENESS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84896714602     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9520-x     Document Type: Article

References (37)

1. Ruggeri, Z. M. (2002). Platelets in atherothrombosis. Nature Medicine, 8(11), 1227-1234. doi: 10.1038/nm1102-1227.
2. Davi, G., & Patrono, C. (2007). Platelet activation and atherothrombosis. The New England Journal of Medicine, 357(24), 2482-2494. doi: 10.1056/NEJMra071014.
3. Danenberg, H. D., Kantak, N., Grad, E., Swaminathan, R. V., Lotan, C., & Edelman, E. R. (2007). C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. European Journal of Haematology, 78(3), 246-252. doi: 10.1111/j.1600-0609.2006. 00808.x.
4. Kalsch, T., Elmas, E., Nguyen, X. D., Suvajac, N., Kluter, H., Borggrefe, M., & Dempfle, C. E. (2007). Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Research in Cardiology, 102(5), 460-466. doi: 10.1007/s00395-007-0667-y.
5. Passacquale, G., Vamadevan, P., Pereira, L., Hamid, C., Corrigall, V., & Ferro, A. (2011). Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PloS one, 6(10), e25595. doi: 10.1371/journal.pone.0025595.
6. Furman, M. I., Benoit, S. E., Barnard, M. R., Valeri, C. R., Borbone, M. L., Becker, R. C., Hechtman, H. B., & Michelson, A. D. (1998). Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology, 31(2), 352-358.
7. Hamilos, M., Sarma, J., Ostojic, M., Cuisset, T., Sarno, G., Melikian, N., Ntalianis, A., Muller, O., Barbato, E., Beleslin, B., Sagic, D., De Bruyne, B., Bartunek, J., & Wijns, W. (2008). Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circulation. Cardiovascular Interventions, 1(3), 193-200. doi: 10.1161/CIRCINTERVENTIONS.108.797928.
8. Gordon, J. B., Ganz, P., Nabel, E. G., Fish, R. D., Zebede, J., Mudge, G. H., Alexander, R. W., & Selwyn, A. P. (1989). Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. The Journal of Clinical Investigation, 83(6), 1946-1952. doi: 10.1172/JCI114103.
9. Robinson, S. D., Harding, S. A., Cummins, P., Din, J. N., Sarma, J., Davidson, I., Fox, K. A., Boon, N. A., & Newby, D. E. (2006). Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets, 17(3), 158-162. doi: 10.1080/17476930500454514.
10. Chatzizisis, Y. S., Coskun, A. U., Jonas, M., Edelman, E. R., Feldman, C. L., & Stone, P. H. (2007). Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. Journal of the American College of Cardiology, 49(25), 2379-2393. doi: 10.1016/j.jacc.2007.02.059.
11. Mangiacapra, F., & Barbato, E. (2013). Clinical implications of platelet-vessel interaction. Journal of Cardiovascular Translational Research, 6(3), 310-315. doi: 10.1007/s12265-012-9441-0.
12. Muller, O., Bartunek, J., Hamilos, M., Berza, C. T., Mangiacapra, F., Ntalianis, A., Vercruysse, K., Duby, C., Wijns, W., De Bruyne, B., Heyndrickx, G. R., Vanderheyden, M., Holz, J. B., & Barbato, E. (2013). von Willebrand factor inhibition improves endothelial function in patients with stable angina. Journal of Cardiovascular Translational Research, 6(3), 364-370. doi: 10.1007/s12265-012-9422-3.
13. Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O., & Wagner, D. D. (1993). Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell, 74(3), 541-554.
14. Massberg, S., Brand, K., Gruner, S., Page, S., Muller, E., Muller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., Nieswandt, B., & Gawaz, M. (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. The Journal of Experimental Medicine, 196(7), 887-896.
15. Theilmeier, G., Michiels, C., Spaepen, E., Vreys, I., Collen, D., Vermylen, J., & Hoylaerts, M. F. (2002). Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood, 99(12), 4486-4493.
16. Diodati, J. G., Dakak, N., Gilligan, D. M., & Quyyumi, A. A. (1998). Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation, 98(1), 17-24.
17. Rosenblum, W. I. (1997). Platelet adhesion and aggregation without endothelial denudation or exposure of basal lamina and/or collagen. Journal of Vascular Research, 34(6), 409-417.
18. Bogaty, P., Brecker, S. J., White, S. E., Stevenson, R. N., El-Tamimi, H., Balcon, R., & Maseri, A. (1993). Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation, 87(6), 1938-1946.
19. Pijls, N. H., De Bruyne, B., Peels, K., Van Der Voort, P. H., Bonnier, H. J., Bartunek, J. K. J. J., & Koolen, J. J. (1996). Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. The New England Journal of Medicine, 334(26), 1703-1708. doi: 10.1056/NEJM199606273342604.
20. De Bruyne, B., Pijls, N. H., Bartunek, J., Kulecki, K., Bech, J. W., De Winter, H., Van Crombrugge, P., Heyndrickx, G. R., & Wijns, W. (2001). Fractional flow reserve in patients with prior myocardial infarction. Circulation, 104(2), 157-162.
21. De Bruyne, B., Pijls, N. H., Barbato, E., Bartunek, J., Bech, J. W., Wijns, W., & Heyndrickx, G. R. (2003). Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation, 107(14), 1877-1883. doi: 10.1161/01.CIR.0000061950.24940.88.
22. Galassi, A. R., Tomasello, S. D., Crea, F., Costanzo, L., Campisano, M. B., Marza, F., & Tamburino, C. (2012). Transient impairment of vasomotion function after successful chronic total occlusion recanalization. Journal of the American College of Cardiology, 59(8), 711-718. doi: 10.1016/j.jacc.2011.10. 894.
23. Hamilos, M. I., Ostojic, M., Beleslin, B., Sagic, D., Mangovski, L., Stojkovic, S., Nedeljkovic, M., Orlic, D., Milosavljevic, B., Topic, D., Karanovic, N., & Wijns, W. (2008). Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. Journal of the American College of Cardiology, 51(22), 2123-2129. doi: 10.1016/j.jacc.2007.12. 059.
24. Harding, S. A., Din, J. N., Sarma, J., Jessop, A., Weatherall, M., Fox, K. A., & Newby, D. E. (2007). Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thrombosis and Haemostasis, 98(2), 451-456.
25. Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233-241. doi: 10.1038/35025203.
26. Egan, K. M., Wang, M., Fries, S., Lucitt, M. B., Zukas, A. M., Pure, E., Lawson, J. A., & FitzGerald, G. A. (2005). Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation, 111(3), 334-342. doi: 10.1161/01.CIR.0000153386.95356.78.
27. Pratico, D., Cyrus, T., Li, H., & FitzGerald, G. A. (2000). Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood, 96(12), 3823-3826.
28. Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., & Wagner, D. D. (1998). The combined role of P- and E-selectins in atherosclerosis. The Journal of Clinical Investigation, 102(1), 145-152. doi: 10.1172/JCI3001.
29. Dong, Z. M., Brown, A. A., & Wagner, D. D. (2000). Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation, 101(19), 2290-2295.
30. Burger, P. C., & Wagner, D. D. (2003). Platelet P-selectin facilitates atherosclerotic lesion development. Blood, 101(7), 2661-2666. doi: 10.1182/blood-2002-07-2209.
31. Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001). Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. The Journal of Cell Biology, 154(3), 485-490. doi: 10.1083/jcb.200105058.
32. McEver, R. P. (2001). Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thrombosis and Haemostasis, 86(3), 746-756.
33. Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., & Kroczek, R. A. (1998). CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391(6667), 591-594. doi: 10.1038/35393.
34. Subramaniam, M., Saffaripour, S., Watson, S. R., Mayadas, T. N., Hynes, R. O., & Wagner, D. D. (1995). Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. The Journal of Experimental Medicine, 181(6), 2277-2282.
35. Sarma, J., Laan, C. A., Alam, S., Jha, A., Fox, K. A., & Dransfield, I. (2002). Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation, 105(18), 2166-2171.
36. De Bruyne, B., Pijls, N. H., Kalesan, B., Barbato, E., Tonino, P. A., Piroth, Z., Jagic, N., Mobius-Winkler, S., Rioufol, G., Witt, N., Kala, P., MacCarthy, P., Engstrom, T., Oldroyd, K. G., Mavromatis, K., Manoharan, G., Verlee, P., Frobert, O., Curzen, N., Johnson, J. B., Juni, P., & Fearon, W. F. (2012). Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. The New England Journal of Medicine, 367(11), 991-1001. doi: 10.1056/NEJMoa1205361.
37. Gremmel, T., Kopp, C. W., Seidinger, D., Giurgea, G. A., Koppensteiner, R., Steiner, S., & Panzer, S. (2009). The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity. Atherosclerosis, 207(2), 608-613. doi: 10.1016/j.atherosclerosis. 2009.05.037.